4.0 Review

Update on the Role of Systemic Vitamin D in Atopic Dermatitis

期刊

PEDIATRIC DERMATOLOGY
卷 30, 期 3, 页码 303-307

出版社

WILEY
DOI: 10.1111/j.1525-1470.2012.01850.x

关键词

-

资金

  1. Abbot
  2. Amgen
  3. Astellas
  4. Rambaxy
  5. Teikoku
  6. Photomedix

向作者/读者索取更多资源

Atopic dermatitis (AD) is a common chronic inflammatory type of eczema. The underlying cause of AD has not been established. Several studies have shown initial epidermal barrier dysfunction with subsequent immune activation as the underlying mechanism. Recently, in addition to its classical role in calcium homeostasis, vitamin D has been recognized for its effect on immunomodulation. Animal studies, case reports, and randomized clinical trials have suggested that vitamin D, through various mechanisms, may alleviate the symptoms of AD. The majority of these studies indicate an inverse relationship between the severity of atopic dermatitis and vitamin D levels. Furthermore, studies have shown that, in individuals with AD who are deficient in vitamin D, repletion of vitamin D results in decreased severity of disease. We present a review of the present literature that suggests a potentially significant role for vitamin D in the treatment of AD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据